Funded Health and Human Services Startups
Across these 8 Health and Human Services rounds, one disclosed outlier stands out: SheMed raised $50M on 2025-10-23, far above the next-largest disclosed r…
Across these 8 Health and Human Services rounds, one disclosed outlier stands out: SheMed raised $50M on 2025-10-23, far above the next-largest disclosed round of $20M (Onto Health, 2026-04-15) and well beyond the $3M and $2M cluster (Zivian Health $3M on 2023-08-22; auryx $2M on 2026-04-30; PREVE $2M on 2025-05-23). Stage classification is also uneven: 3 of 8 entries are “Series Unknown” (Move To Happiness on 2026-02-10; Alderley Lighthouse Labs on 2023-08-14; plus the otherwise notable mismatch between the $50M and the many seed/pre-seed-sized rounds). Geographically, the list is split between the US and Europe: the UK appears twice (auryx and SheMed, London) and the US twice (Onto Health, Colorado; Zivian Health, Ohio), while Belgium, Netherlands, and Australia each show a single company.
Temporally, the dataset spans from 2023-08-14 (Alderley Lighthouse Labs) to 2026-04-30 (auryx). Several deals cluster in 2025–2026, with 4 of the 8 rounds landing in 2025–2026 (SheMed 2025-10-23; PREVE 2025-05-23; VRelax 2024-05-18; plus auryx and Onto Health in 2026).
Most recent rounds
8 shownRelated listings
Frequently asked
Which disclosed round is the size outlier in Health and Human Services here, and what’s the size gap versus the rest?
SheMed’s $50M (2025-10-23) is the only disclosed round above $20M; the next-largest disclosed amount is Onto Health’s $20M (2026-04-15), while several others sit at $3M (Zivian Health, 2023-08-22) or $2M (auryx, 2026-04-30; PREVE, 2025-05-23).
Do these deals cluster in time or are they evenly spread across the 2023–2026 window shown?
They’re somewhat front-loaded toward the more recent period shown: 4 of 8 rounds occur in 2025–2026 (SheMed $50M on 2025-10-23; PREVE $2M on 2025-05-23; Onto Health $20M on 2026-04-15; auryx $2M on 2026-04-30). The remaining entries span 2023-08-14 to 2024-05-18 (Alderley Lighthouse Labs; Zivian Health; VRelax).
Are any cities or countries over-represented in this list, or is it mostly one-offs?
The UK appears twice with two different entries in London (auryx on 2026-04-30 and SheMed on 2025-10-23). The US also appears twice (Onto Health in Parker, Colorado on 2026-04-15 and Zivian Health in Cleveland, Ohio on 2023-08-22), while Belgium (Move To Happiness), Netherlands (VRelax), and Australia (PREVE) each appear once.
What does the stage mix suggest—does “Series Unknown” dominate, or do known early rounds cluster elsewhere?
“Series Unknown” accounts for 3 of 8 entries (Move To Happiness, 2026-02-10; Alderley Lighthouse Labs, 2023-08-14; and one additional listed item with an unknown series). Known stages also concentrate at the early end, with multiple seed/pre-seed classifications such as VRelax as Seed ($1M on 2024-05-18) and auryx as Pre-Seed ($2M on 2026-04-30).
Which entries were among the most recent rounds by date, and do they change the overall pattern?
The two most recent disclosed rounds are auryx ($2M on 2026-04-30, Pre-Seed) and Onto Health ($20M on 2026-04-15, Series A). Together they reinforce the broader pattern: even the newer Series A disclosed at $20M remains far below the $50M SheMed round (2025-10-23).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.